Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.03)
# 1,132
Out of 4,667 analysts
27
Total ratings
66.67%
Success rate
50.2%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $0.10 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $368.16 | -6.56% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $11.60 | +361.21% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $34.97 | +14.38% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $10.19 | +194.41% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.16 | +64.68% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $11.47 | +39.49% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.38 | +31,586.39% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.51 | +4,374.71% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $5.00 | +920.00% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $9.06 | +76.60% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $2.38 | +1,790.76% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.10
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $368.16
Upside: -6.56%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $11.60
Upside: +361.21%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $34.97
Upside: +14.38%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $10.19
Upside: +194.41%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.16
Upside: +64.68%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $11.47
Upside: +39.49%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.38
Upside: +31,586.39%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.51
Upside: +4,374.71%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $5.00
Upside: +920.00%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $9.06
Upside: +76.60%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $2.38
Upside: +1,790.76%